Overview
5th Annual Physiology of Pacing Symposium
Registration is currently closed for the symposium. Please contact Karen Catino at kcatino@achlcme.org for questions.
- Outline current and emerging therapies for cardiac pacing, with emphasis on physiologic mechanism and responses to cardiac resynchronization therapy.
- Review the relationship between electrical stimulation of the heart with mechanics of myocardial contraction.
- Discuss the evolving role of conduction system pacing (CSP) strategies including His-bundle Pacing (HBP), left bundle branch area pacing (LBBAP), and left ventricular septal pacing (LVSP) for standard permanent pacing as well as for cardiac resynchronization.
- Review history and recent advances in CSP with emerging clinical situations and applications in the setting of narrow and wide QRS morphology patients.
- Describe challenges and methods for implantation technique of permanent His-bundle pacemaker.
- Review the relevant anatomy of the membranous septum, conduction system with relation to the right atrium, and tricuspid valve.
- Explain the potential role of His-bundle Pacing for patients with atrial fibrillation.
- Summarize strategies and clinical evidence for the various approaches to achieve cardiac resynchronization including leadless technology, multisite pacing, and left ventricular (LV) endocardial pacing.
- Discuss strategies for improving current technologies and tools for cardiac resynchronization.
16 W. Adams St.
Chicago , IL 60603 USA
Click here to view location map
Comment: COVID 19 Protocols: Participants attending the 5th Annual Physiology of Pacing Symposium must be vaccinated. Proof of vaccination and ID will be requested upon arrival.
Cancellations/Refunds and Fellows Reimbursement:
Full refunds will only be given prior to October 2, 2021. After October 2, no refunds will be provided. All refund requests should be submitted to mstradal@achlcme.org.
Please note: Fellows who are recorded onsite will be refunded their pre-registration fee of $50 following the meeting. Please allow at least four weeks for refund processing.
Medical Director & Dyad Leader, Cardiovascular Service Line
CHI Franciscan, Pacific Northwest
CommonSpirit Health
Adjunct Assistant Professor, Indiana University School of Medicine
TBD
Niraj Varma, MD
Cleveland Clinic
Santosh Padala, MD
TBD
Suneet Mittal, MD
Director, Electrophysiology Associate Chair, Cardiology The Valley Hospital
Atul Verma, MD
TBD
Karol Curila, PhD
Cardiocenter, 3-rd Faculty of Medicine, Charles University in Prague
Kenneth Ellenbogen, MD
Kimmerling Professor of Medicine VCU School of Medicine Richmond, VA
Mikhael El-Chami, MD
TBD
Gaurav Upadhyay, MD
TBD
Pugal Vijayaraman, MD
TBD
Faiz Subzposh, MD
TBD
Jeanne Poole, MD
University of Washington
Frits Prinzen, PhD
TBD
Anne Curtis, MD
Charles and Mary Bauer Professor and Chair of Medicine Jacobs School of Medicine and Biomedical Sciences University at Buffalo
Jagmeet Singh, MD
TBD
Kevin Vernooy, MD
Department of cardiology, Maastricht University Medical Center, Maastricht, The Netherlands
Parik Sharma, MD, MPH, FACC, FHRS
Parikshit (Parik) S Sharma, MD, MPH, FACC, FHRS Associate Professor of Medicine Heart Rhythm Specialist Chief, Section of Electrophysiology Director of Electrophysiology Laboratory Dept of Internal medicine, Division of Cardiology Rush University Medical Center Chicago, IL
Michael Gold, MD
TBD
ACHL requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
Faculty disclosures will be provided before the meeting.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.